Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1747743

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1747743

Sex Reassignment Surgery

PUBLISHED:
PAGES: 176 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Global Sex Reassignment Surgery Market to Reach US$1.2 Billion by 2030

The global market for Sex Reassignment Surgery estimated at US$711.7 Million in the year 2024, is expected to reach US$1.2 Billion by 2030, growing at a CAGR of 9.4% over the analysis period 2024-2030. Transgender Male to Female, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$772.8 Million by the end of the analysis period. Growth in the Transgender Female to Male segment is estimated at 8.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$187.1 Million While China is Forecast to Grow at 8.6% CAGR

The Sex Reassignment Surgery market in the U.S. is estimated at US$187.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$188.8 Million by the year 2030 trailing a CAGR of 8.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.4% and 7.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.4% CAGR.

Global Sex Reassignment Surgery Market - Key Trends & Drivers Summarized

Why Is Sex Reassignment Surgery Gaining Strategic Relevance Across Gender-Affirming Healthcare, Policy Reform, and Surgical Specialization Domains?

Sex reassignment surgery (SRS)-also known as gender confirmation or gender-affirming surgery-is experiencing increased global visibility and demand as healthcare systems, legal frameworks, and social attitudes evolve toward greater inclusion of transgender and non-binary individuals. These procedures, encompassing genital reconstruction, chest/top surgery, facial feminization or masculinization, and ancillary interventions, represent a critical step in gender-affirming care for many individuals seeking physiological alignment with their gender identity.

Rising awareness, de-stigmatization of gender dysphoria, and expanding insurance coverage in select markets are enabling more individuals to access surgical transition services. Medical institutions are increasingly recognizing the psychological, social, and physiological benefits of comprehensive gender-affirming care, leading to the expansion of specialized surgical programs within urology, plastic surgery, gynecology, and endocrinology departments. Advocacy for legal gender recognition rights and trans-inclusive health policies is further elevating the legitimacy and integration of SRS within mainstream healthcare delivery.

How Are Surgical Innovations, Institutional Accreditation, and Holistic Care Models Advancing the Field of Sex Reassignment Surgery?

Surgical advancements are significantly improving outcomes, reducing complications, and expanding procedural options for individuals undergoing sex reassignment. Techniques such as penile inversion vaginoplasty, phalloplasty using radial forearm free flaps, metoidioplasty, and chest contouring are being refined for functional and aesthetic optimization. Robotics, 3D surgical planning, and microsurgical innovations are contributing to enhanced nerve preservation, vascular integration, and reduced recovery times.

Accreditation standards-such as those from the World Professional Association for Transgender Health (WPATH)-are influencing institutional protocols, guiding multidisciplinary care pathways, and ensuring ethical surgical eligibility and informed consent. Comprehensive care models now integrate psychological assessment, hormonal therapy, voice therapy, post-operative rehabilitation, and peer support, enabling higher quality of life outcomes and long-term care continuity. Leading centers of excellence are partnering with community health organizations to scale access, reduce stigma, and improve patient navigation across clinical and non-clinical dimensions.

Which Regional Healthcare Systems, Patient Demographics, and Provider Networks Are Driving Market Expansion in Sex Reassignment Surgery?

North America and Western Europe are at the forefront of SRS adoption, driven by maturing insurance policies, legal protections for transgender individuals, and concentration of experienced surgical providers. The United States, in particular, is witnessing increased procedural volumes among younger adult populations, facilitated by expanding Medicaid and private coverage in progressive states. Canada, Germany, the Netherlands, and Sweden have established robust frameworks for publicly funded gender-affirming care.

Asia-Pacific is emerging as a high-growth region, with Thailand and South Korea recognized as global medical tourism hubs for SRS, owing to surgical expertise, cost efficiency, and comprehensive post-operative services. India is witnessing growing domestic and international demand alongside recent legal advances for transgender rights. Latin America and the Middle East remain nascent markets, where socio-cultural barriers and regulatory constraints still limit accessibility, although awareness and provider availability are gradually improving.

Provider networks are diversifying, with academic hospitals, specialty gender clinics, and private surgical centers competing to offer inclusive, evidence-based care. Cross-referral systems between endocrinologists, mental health professionals, and surgeons are streamlining patient pathways, while digital consultation platforms are reducing geographic barriers to care access. Training initiatives and global fellowships in gender surgery are addressing provider shortages and standardizing quality across regions.

What Are the Factors Driving Growth in the Sex Reassignment Surgery Market?

The sex reassignment surgery market is expanding as gender-affirming healthcare gains structural legitimacy across clinical, legal, and policy landscapes. The convergence of medical innovation, human rights advocacy, and evolving patient-centered care models is solidifying the role of SRS in comprehensive transgender health delivery.

Key growth drivers include increasing insurance coverage and institutional support, expanding procedural refinement, rising transgender visibility, and growing demand for holistic, multidisciplinary care models. Global momentum toward gender equity and inclusion in healthcare is further accelerating policy and investment shifts in favor of access to gender-affirming surgeries.

As gender identity becomes a central dimension of healthcare personalization and rights-based access, could sex reassignment surgery emerge as a global benchmark for inclusive, multidisciplinary, and ethically integrated medical innovation?

SCOPE OF STUDY:

The report analyzes the Sex Reassignment Surgery market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Gender Identity (Transgender Male to Female, Transgender Female to Male, Non-Binary); Surgery Type (Facial Feminization Surgery, Breast Augmentation or Top Surgery, Body Contouring, Vaginoplasty, Phalloplasty, Metoidioplasty, Other Surgery Types); End-Use (Hospitals, Specialty Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 36 Featured) -

  • Boston Medical Center
  • Center for Transgender Medicine and Surgery at Mount Sinai
  • Chettawut Plastic Surgery Center
  • GRS Montreal
  • IM GENDER (IM CLINIC)
  • Johns Hopkins Center for Transgender Health
  • Kamol Cosmetic Hospital
  • London Transgender Clinic
  • Ocean Clinic Marbella
  • Phuket Plastic Surgery Institute (PPSI)
  • Rumer Cosmetic Surgery
  • Sheba Medical Center
  • The Gender Surgery Program at Vancouver General Hospital
  • The London Transgender Clinic
  • The University of California, San Francisco (UCSF) Transgender Care
  • TransHealthCare
  • University Medical Center Groningen (UMCG)
  • University Medical Center Utrecht (UMCU)
  • University of Michigan Comprehensive Gender Services Program
  • Yanhee International Hospital

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

Product Code: MCP35742

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Sex Reassignment Surgery - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Societal Acceptance of Gender Diversity Throws the Spotlight on Sex Reassignment Surgery (SRS) Services
    • Growth in Transgender Healthcare Awareness Spurs Demand for Gender-Affirming Surgical Interventions
    • Expansion of Urology, Plastic Surgery, and Reconstructive Specialties Drives Multi-Disciplinary Collaboration
    • Use of Advanced Surgical Techniques for Phalloplasty, Vaginoplasty, and Chest Reconstruction Supports Tailored Procedures
    • Rising Access to Hormonal and Psychological Support Pre-Surgery Improves Surgical Readiness and Recovery
    • Global Expansion of Clinics and Medical Tourism Hubs Provides Options for Cross-Border Patients
    • Increased Inclusion of SRS in Health Insurance and National Health Schemes Drives Affordability and Access
    • Medical Device Innovation in Tissue Expanders, Implants, and Nerve-Sparing Tools Enhances Functional Outcomes
    • Growing Role of Advocacy Groups and Legal Reforms Enhances Access to Gender-Affirming Care Pathways
    • Integration of Digital Consultation and Follow-Up Platforms Supports Long-Term Patient Monitoring and Continuity
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Sex Reassignment Surgery Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Sex Reassignment Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Transgender Male to Female by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Transgender Male to Female by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Transgender Female to Male by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Transgender Female to Male by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Non-Binary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Non-Binary by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Surgery Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Other Surgery Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Facial Feminization Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Facial Feminization Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Breast Augmentation or Top Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Breast Augmentation or Top Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Body Contouring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Body Contouring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Vaginoplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Vaginoplasty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Phalloplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Phalloplasty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Metoidioplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Metoidioplasty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Sex Reassignment Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 30: USA Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Gender Identity - Transgender Male to Female, Transgender Female to Male and Non-Binary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Sex Reassignment Surgery by Gender Identity - Percentage Breakdown of Value Sales for Transgender Male to Female, Transgender Female to Male and Non-Binary for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Surgery Type - Other Surgery Types, Facial Feminization Surgery, Breast Augmentation or Top Surgery, Body Contouring, Vaginoplasty, Phalloplasty and Metoidioplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Sex Reassignment Surgery by Surgery Type - Percentage Breakdown of Value Sales for Other Surgery Types, Facial Feminization Surgery, Breast Augmentation or Top Surgery, Body Contouring, Vaginoplasty, Phalloplasty and Metoidioplasty for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Sex Reassignment Surgery by End-Use - Hospitals, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Sex Reassignment Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Other End-Uses for the Years 2025 & 2030
  • CANADA
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Gender Identity - Transgender Male to Female, Transgender Female to Male and Non-Binary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Sex Reassignment Surgery by Gender Identity - Percentage Breakdown of Value Sales for Transgender Male to Female, Transgender Female to Male and Non-Binary for the Years 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Surgery Type - Other Surgery Types, Facial Feminization Surgery, Breast Augmentation or Top Surgery, Body Contouring, Vaginoplasty, Phalloplasty and Metoidioplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Sex Reassignment Surgery by Surgery Type - Percentage Breakdown of Value Sales for Other Surgery Types, Facial Feminization Surgery, Breast Augmentation or Top Surgery, Body Contouring, Vaginoplasty, Phalloplasty and Metoidioplasty for the Years 2025 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Sex Reassignment Surgery by End-Use - Hospitals, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Sex Reassignment Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Other End-Uses for the Years 2025 & 2030
  • JAPAN
    • Sex Reassignment Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Gender Identity - Transgender Male to Female, Transgender Female to Male and Non-Binary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Sex Reassignment Surgery by Gender Identity - Percentage Breakdown of Value Sales for Transgender Male to Female, Transgender Female to Male and Non-Binary for the Years 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Surgery Type - Other Surgery Types, Facial Feminization Surgery, Breast Augmentation or Top Surgery, Body Contouring, Vaginoplasty, Phalloplasty and Metoidioplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan 6-Year Perspective for Sex Reassignment Surgery by Surgery Type - Percentage Breakdown of Value Sales for Other Surgery Types, Facial Feminization Surgery, Breast Augmentation or Top Surgery, Body Contouring, Vaginoplasty, Phalloplasty and Metoidioplasty for the Years 2025 & 2030
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Sex Reassignment Surgery by End-Use - Hospitals, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Japan 6-Year Perspective for Sex Reassignment Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Other End-Uses for the Years 2025 & 2030
  • CHINA
    • Sex Reassignment Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 48: China Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Gender Identity - Transgender Male to Female, Transgender Female to Male and Non-Binary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Sex Reassignment Surgery by Gender Identity - Percentage Breakdown of Value Sales for Transgender Male to Female, Transgender Female to Male and Non-Binary for the Years 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Surgery Type - Other Surgery Types, Facial Feminization Surgery, Breast Augmentation or Top Surgery, Body Contouring, Vaginoplasty, Phalloplasty and Metoidioplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China 6-Year Perspective for Sex Reassignment Surgery by Surgery Type - Percentage Breakdown of Value Sales for Other Surgery Types, Facial Feminization Surgery, Breast Augmentation or Top Surgery, Body Contouring, Vaginoplasty, Phalloplasty and Metoidioplasty for the Years 2025 & 2030
    • TABLE 52: China Recent Past, Current & Future Analysis for Sex Reassignment Surgery by End-Use - Hospitals, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: China 6-Year Perspective for Sex Reassignment Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Other End-Uses for the Years 2025 & 2030
  • EUROPE
    • Sex Reassignment Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Sex Reassignment Surgery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Gender Identity - Transgender Male to Female, Transgender Female to Male and Non-Binary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Sex Reassignment Surgery by Gender Identity - Percentage Breakdown of Value Sales for Transgender Male to Female, Transgender Female to Male and Non-Binary for the Years 2025 & 2030
    • TABLE 58: Europe Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Surgery Type - Other Surgery Types, Facial Feminization Surgery, Breast Augmentation or Top Surgery, Body Contouring, Vaginoplasty, Phalloplasty and Metoidioplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Europe 6-Year Perspective for Sex Reassignment Surgery by Surgery Type - Percentage Breakdown of Value Sales for Other Surgery Types, Facial Feminization Surgery, Breast Augmentation or Top Surgery, Body Contouring, Vaginoplasty, Phalloplasty and Metoidioplasty for the Years 2025 & 2030
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Sex Reassignment Surgery by End-Use - Hospitals, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Europe 6-Year Perspective for Sex Reassignment Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Other End-Uses for the Years 2025 & 2030
  • FRANCE
    • Sex Reassignment Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Gender Identity - Transgender Male to Female, Transgender Female to Male and Non-Binary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Sex Reassignment Surgery by Gender Identity - Percentage Breakdown of Value Sales for Transgender Male to Female, Transgender Female to Male and Non-Binary for the Years 2025 & 2030
    • TABLE 64: France Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Surgery Type - Other Surgery Types, Facial Feminization Surgery, Breast Augmentation or Top Surgery, Body Contouring, Vaginoplasty, Phalloplasty and Metoidioplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: France 6-Year Perspective for Sex Reassignment Surgery by Surgery Type - Percentage Breakdown of Value Sales for Other Surgery Types, Facial Feminization Surgery, Breast Augmentation or Top Surgery, Body Contouring, Vaginoplasty, Phalloplasty and Metoidioplasty for the Years 2025 & 2030
    • TABLE 66: France Recent Past, Current & Future Analysis for Sex Reassignment Surgery by End-Use - Hospitals, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: France 6-Year Perspective for Sex Reassignment Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Other End-Uses for the Years 2025 & 2030
  • GERMANY
    • Sex Reassignment Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Gender Identity - Transgender Male to Female, Transgender Female to Male and Non-Binary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Sex Reassignment Surgery by Gender Identity - Percentage Breakdown of Value Sales for Transgender Male to Female, Transgender Female to Male and Non-Binary for the Years 2025 & 2030
    • TABLE 70: Germany Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Surgery Type - Other Surgery Types, Facial Feminization Surgery, Breast Augmentation or Top Surgery, Body Contouring, Vaginoplasty, Phalloplasty and Metoidioplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Germany 6-Year Perspective for Sex Reassignment Surgery by Surgery Type - Percentage Breakdown of Value Sales for Other Surgery Types, Facial Feminization Surgery, Breast Augmentation or Top Surgery, Body Contouring, Vaginoplasty, Phalloplasty and Metoidioplasty for the Years 2025 & 2030
    • TABLE 72: Germany Recent Past, Current & Future Analysis for Sex Reassignment Surgery by End-Use - Hospitals, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Germany 6-Year Perspective for Sex Reassignment Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Other End-Uses for the Years 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Gender Identity - Transgender Male to Female, Transgender Female to Male and Non-Binary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Sex Reassignment Surgery by Gender Identity - Percentage Breakdown of Value Sales for Transgender Male to Female, Transgender Female to Male and Non-Binary for the Years 2025 & 2030
    • TABLE 76: Italy Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Surgery Type - Other Surgery Types, Facial Feminization Surgery, Breast Augmentation or Top Surgery, Body Contouring, Vaginoplasty, Phalloplasty and Metoidioplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Italy 6-Year Perspective for Sex Reassignment Surgery by Surgery Type - Percentage Breakdown of Value Sales for Other Surgery Types, Facial Feminization Surgery, Breast Augmentation or Top Surgery, Body Contouring, Vaginoplasty, Phalloplasty and Metoidioplasty for the Years 2025 & 2030
    • TABLE 78: Italy Recent Past, Current & Future Analysis for Sex Reassignment Surgery by End-Use - Hospitals, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Italy 6-Year Perspective for Sex Reassignment Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Other End-Uses for the Years 2025 & 2030
  • UNITED KINGDOM
    • Sex Reassignment Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Gender Identity - Transgender Male to Female, Transgender Female to Male and Non-Binary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Sex Reassignment Surgery by Gender Identity - Percentage Breakdown of Value Sales for Transgender Male to Female, Transgender Female to Male and Non-Binary for the Years 2025 & 2030
    • TABLE 82: UK Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Surgery Type - Other Surgery Types, Facial Feminization Surgery, Breast Augmentation or Top Surgery, Body Contouring, Vaginoplasty, Phalloplasty and Metoidioplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: UK 6-Year Perspective for Sex Reassignment Surgery by Surgery Type - Percentage Breakdown of Value Sales for Other Surgery Types, Facial Feminization Surgery, Breast Augmentation or Top Surgery, Body Contouring, Vaginoplasty, Phalloplasty and Metoidioplasty for the Years 2025 & 2030
    • TABLE 84: UK Recent Past, Current & Future Analysis for Sex Reassignment Surgery by End-Use - Hospitals, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: UK 6-Year Perspective for Sex Reassignment Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Other End-Uses for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Gender Identity - Transgender Male to Female, Transgender Female to Male and Non-Binary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Sex Reassignment Surgery by Gender Identity - Percentage Breakdown of Value Sales for Transgender Male to Female, Transgender Female to Male and Non-Binary for the Years 2025 & 2030
    • TABLE 88: Rest of Europe Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Surgery Type - Other Surgery Types, Facial Feminization Surgery, Breast Augmentation or Top Surgery, Body Contouring, Vaginoplasty, Phalloplasty and Metoidioplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of Europe 6-Year Perspective for Sex Reassignment Surgery by Surgery Type - Percentage Breakdown of Value Sales for Other Surgery Types, Facial Feminization Surgery, Breast Augmentation or Top Surgery, Body Contouring, Vaginoplasty, Phalloplasty and Metoidioplasty for the Years 2025 & 2030
    • TABLE 90: Rest of Europe Recent Past, Current & Future Analysis for Sex Reassignment Surgery by End-Use - Hospitals, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of Europe 6-Year Perspective for Sex Reassignment Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Other End-Uses for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Sex Reassignment Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Gender Identity - Transgender Male to Female, Transgender Female to Male and Non-Binary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Sex Reassignment Surgery by Gender Identity - Percentage Breakdown of Value Sales for Transgender Male to Female, Transgender Female to Male and Non-Binary for the Years 2025 & 2030
    • TABLE 94: Asia-Pacific Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Surgery Type - Other Surgery Types, Facial Feminization Surgery, Breast Augmentation or Top Surgery, Body Contouring, Vaginoplasty, Phalloplasty and Metoidioplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Asia-Pacific 6-Year Perspective for Sex Reassignment Surgery by Surgery Type - Percentage Breakdown of Value Sales for Other Surgery Types, Facial Feminization Surgery, Breast Augmentation or Top Surgery, Body Contouring, Vaginoplasty, Phalloplasty and Metoidioplasty for the Years 2025 & 2030
    • TABLE 96: Asia-Pacific Recent Past, Current & Future Analysis for Sex Reassignment Surgery by End-Use - Hospitals, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Asia-Pacific 6-Year Perspective for Sex Reassignment Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Other End-Uses for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Gender Identity - Transgender Male to Female, Transgender Female to Male and Non-Binary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Sex Reassignment Surgery by Gender Identity - Percentage Breakdown of Value Sales for Transgender Male to Female, Transgender Female to Male and Non-Binary for the Years 2025 & 2030
    • TABLE 100: Rest of World Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Surgery Type - Other Surgery Types, Facial Feminization Surgery, Breast Augmentation or Top Surgery, Body Contouring, Vaginoplasty, Phalloplasty and Metoidioplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Rest of World 6-Year Perspective for Sex Reassignment Surgery by Surgery Type - Percentage Breakdown of Value Sales for Other Surgery Types, Facial Feminization Surgery, Breast Augmentation or Top Surgery, Body Contouring, Vaginoplasty, Phalloplasty and Metoidioplasty for the Years 2025 & 2030
    • TABLE 102: Rest of World Recent Past, Current & Future Analysis for Sex Reassignment Surgery by End-Use - Hospitals, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Rest of World 6-Year Perspective for Sex Reassignment Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Other End-Uses for the Years 2025 & 2030

IV. COMPETITION

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!